Impact of COVID-19 on mucormycosis presentation and laboratory values: A comparative analysis.

ABSTRACT:

Background

The COVID-19 pandemic has led to an alarming increase in mucormycosis coinfections and its rapid progression. The overlapping risk factors and symptoms between COVID-19 and mucormycosis further complicate prompt detection, which is crucial for patient survival. This study aims to investigate potential differences in mucormycosis progression, initial symptom presentation, and laboratory value alterations in mucormycosis patients with COVID-19 history to enhance diagnostic accuracy and improve outcomes in this complex clinical scenario.

Methodology

This retrospective cohort study, conducted from April 1, 2021, to March 31, 2022, examined 102 patients diagnosed with mucormycosis at two primary teaching hospitals. Patients were categorized into two groups based on COV

SUBMITTER: Hejazi S 

PROVIDER: S-EPMC12047787 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature